Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment. - Wikidata - wikimedia - TriplyDB

Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

http://www.wikidata.org/entity/Q33893155

about

Interpatient variability in dexmedetomidine response: a survey of the literature GPCRs in stem cell function Hypothalamic subependymal niche: a novel site of the adult neurogenesis.Norepinephrine directly activates adult hippocampal precursors via beta3-adrenergic receptors.Early stress evokes age-dependent biphasic changes in hippocampal neurogenesis, BDNF expression, and cognition Opposing effects of α2- and β-adrenergic receptor stimulation on quiescent neural precursor cell activity and adult hippocampal neurogenesis.α2 adrenergic receptor dysregulation in depressive disorders: implications for the neurobiology of depression and antidepressant therapy Is acupuncture "stimulation" a misnomer? A case for using the term "blockade".Adjunctive treatment with asenapine augments the escitalopram-induced effects on monoaminergic outflow and glutamatergic neurotransmission in the medial prefrontal cortex of the rat The antidepressant desipramine is an arrestin-biased ligand at the α(2A)-adrenergic receptor driving receptor down-regulation in vitro and in vivo.Participation of brainstem monoaminergic nuclei in behavioral depression Noradrenergic antidepressant responses to desipramine in vivo are reciprocally regulated by arrestin3 and spinophilin.Neurotoxicity of prenatal alcohol exposure on medullary pre-Bötzinger complex neurons in neonatal rats.A novel natural product inspired scaffold with robust neurotrophic, neurogenic and neuroprotective action G-protein-coupled receptors in adult neurogenesis.α₂-Adrenoceptor functionality in postmortem frontal cortex of depressed suicide victims.Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?Tamalin is a critical mediator of electroconvulsive shock-induced adult neuroplasticity Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.Antidepressants for neuro-regeneration: from depression to Alzheimer's disease.Therapeutic Potential of Selectively Targeting the α2C-Adrenoceptor in Cognition, Depression, and Schizophrenia-New Developments and Future Perspective.Prohexadione, a plant growth regulator, inhibits histone lysine demethylases and modulates epigenetics.A 2-oxa-spiro[5.4]decane scaffold displays neurotrophic, neurogenic and anti-neuroinflammatory activities with high potential for development as a versatile CNS therapeutic.Implication of NGF and endocannabinoid signaling in the mechanism of action of sesamol: a multi-target natural compound with therapeutic potential.The endocannabinoid system and NGF are involved in the mechanism of action of resveratrol: a multi-target nutraceutical with therapeutic potential in neuropsychiatric disorders.Enhanced anti-immobility effects of Sanggenon G isolated from the root bark of Morus alba combined with the α2-antagonist yohimbine in the rat forced swim test.Alpha2-adrenergic receptor activation regulates cortical interneuron migration.The CB₁ receptor-mediated endocannabinoid signaling and NGF: the novel targets of curcumin.Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response.Antidepressants in the treatment of stroke.Noradrenergic regulation of plasticity marker expression in the adult rodent piriform cortex.

P2860

Q26994769-43483B9A-2EC6-4560-8F1F-3C10BB910F86 Q27003270-8C2D816B-982E-40D8-B617-61DB46702675 Q33718774-5878191D-1904-47B5-AEF4-5791B784BB71 Q33725000-E0FA397B-07A3-4F18-B461-4BA61CE83771 Q33732961-A4FAA1FE-65BC-42EF-801C-D5C0CF125914 Q33747754-FFFDA3F9-EAE2-413D-A75A-C0CA7B38520F Q34295208-32790AE0-CDC0-4CAC-B130-1794D914A837 Q34636303-9CD5AB53-CE94-4C5D-A505-6CC56E12F530 Q35179053-1AD9DFDA-B0B8-45A4-AC99-AFB64C80F2CD Q35371943-47E26C56-6963-4171-8572-EB769036084F Q35421880-06DDA8D8-E49C-423A-B75F-2857D4A0654B Q35856932-E5692317-39B7-4DEF-B809-7E8CD3D65D3C Q35969689-F2D3AD85-8A53-4337-8AEB-0AF99344E7CC Q36099065-78A8AC5A-9F0F-4FB8-BD9F-948C1E23EAD3 Q36105469-C15F5E27-27AD-4D89-9F9B-9FFBA2C94A4B Q36583816-66263D8E-FE66-484E-88A7-4D1D6FE3D93D Q36922331-F182106E-9BAD-4F23-A52F-26A51AF3A2DB Q37183514-5FE8CEE7-0F18-4436-B995-89E71E47ABB0 Q37191597-41EAF0AB-80FB-400E-99BF-42F107798A8B Q38121519-DF93DB6A-B6E3-4065-9CC4-C8BDE5307693 Q38152966-BBA4B44F-C1D5-47AD-BB70-DA515D83EF4B Q38635337-42F59F12-A78D-47F1-84D6-1CDA6DED69F3 Q41680944-C6A72043-A115-4C2D-B490-D18EFE5F39BC Q42267406-C7EE9B26-33C0-4D76-881D-D7018222C2F4 Q46061859-167EFE12-4BE6-4408-8DFA-48544CDB3861 Q47595268-08AB52ED-7A34-4334-9FF0-B2B5DB3BA7CB Q48063452-3A884E1A-C380-4088-945B-4C3B6789617A Q48437673-9AD6D1F1-A42C-4842-8A79-E83E5A0FCE52 Q48670584-E530A34B-38DF-4D70-80B2-5E0744CFE5C9 Q48825903-5DD56FAC-D5BE-4FF6-BA25-E3F240C430AF Q49110624-2940D0E7-0D79-46D2-A1C3-5B0A29EBBF29 Q54965588-96CEAD91-32B8-4DA5-B22D-4DA1F5D8D7DB

P2860

Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.

http://www.wikidata.org/entity/Q33893155

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Alpha2-adrenoceptor blockade a ...... onic antidepressant treatment.

@ast

Alpha2-adrenoceptor blockade a ...... onic antidepressant treatment.

@en

type

label

Alpha2-adrenoceptor blockade a ...... onic antidepressant treatment.

@ast

Alpha2-adrenoceptor blockade a ...... onic antidepressant treatment.

@en

prefLabel

Alpha2-adrenoceptor blockade a ...... onic antidepressant treatment.

@ast

Alpha2-adrenoceptor blockade a ...... onic antidepressant treatment.

@en

P1433

Q33893155-2EFA5A56-59F2-4BE2-B782-32FCF1A6C178

P1476

Q33893155-4D2467BE-B2D8-4A18-9D63-F739D6459768

P2093

Q33893155-0AA67FD6-20F6-41C5-B3D5-AFE633AA4FB5

Q33893155-1F6C542F-1D31-46AA-887A-D2C1EA48DD3F

Q33893155-26FA7A8D-277D-4FBD-B65B-51F706C0EFA3

Q33893155-5D72ECBA-0F30-46AC-8ECD-38C6F7A28474

Q33893155-79F7A30B-A786-4AC9-8E16-E87A5B9B012C

Q33893155-7F33558E-C5B2-40E5-BC00-43825B57937D

Q33893155-92B4284A-1298-4612-8ABB-A533AB87A321

Q33893155-93AD3759-79C2-42CD-AB24-9E021614C123

Q33893155-94AECC22-6E42-490D-AD3B-55F6F4260C8D

Q33893155-98DD958A-CFF2-49A9-92E8-A113B54B0F45

P2860

Q33893155-0C8341A4-878A-4543-B49D-90BA5B6E66F2

Q33893155-1591D401-4895-4433-B1BE-7DE2004306CB

Q33893155-19889A81-3847-458E-A530-B1062D974DA7

Q33893155-19AD5BD8-5ABA-42C1-B168-93DB15D4F279

Q33893155-1EF85697-05A2-47F9-B313-53BA88BFC081

Q33893155-26BE3D23-C0BE-437A-853F-9CEA8C570BFD

Q33893155-2B43BF4D-75BA-46C6-B4F5-2EA0ADE022DB

Q33893155-2D7519FB-41D2-44DA-AADE-F4F42D8E8F81

Q33893155-30CAC806-090D-4275-BF3D-AD6EE609C9BF

Q33893155-30F9C969-85EA-44DC-818F-FED79C13CE06

P304

Q33893155-65941996-7422-478E-8B7D-D28EF828178C

P31

Q33893155-D210AC46-E7B3-4221-976A-39898E9B64DC

P356

Q33893155-98B895DD-3F4A-4879-9B84-51F764952308

P407

Q33893155-EA506AFB-79EB-4D5A-A267-4751B0C58457

P433

Q33893155-AD2E641A-9592-4338-992C-DBF5AAC7BA93

P478

Q33893155-089180B2-0627-46C8-AA57-53DC86058511

P50

Q33893155-134AFB61-4D23-40A0-A65A-1F38B1C04CF2

Q33893155-BE5885D8-045A-426D-BEF9-889E91F85CC4

P577

Q33893155-8CCAD9A7-0A30-411D-9118-E24828E6F360

P698

Q33893155-A24C1B74-E5DA-4799-AAE2-DA0E1A174E91

P932

Q33893155-0991005C-EB7C-4E23-8205-FF6CC7D63380

P356

JNEUROSCI.2309-09.2010

P1433

Journal of Neuroscience

P1476

Alpha2-adrenoceptor blockade a ...... ronic antidepressant treatment

@en

P2093

David Weinshenker

http://www.w3.org/2001/XMLSchema#string

Dhanisha Jhaveri

http://www.w3.org/2001/XMLSchema#string

Karen Rommelfanger

http://www.w3.org/2001/XMLSchema#string

Kimberly Fernandes

http://www.w3.org/2001/XMLSchema#string

Krishna C Vadodaria

http://www.w3.org/2001/XMLSchema#string

Lutz Hein

http://www.w3.org/2001/XMLSchema#string

Perry Bartlett

http://www.w3.org/2001/XMLSchema#string

Shanker Jha

http://www.w3.org/2001/XMLSchema#string

Sudhirkumar U Yanpallewar

http://www.w3.org/2001/XMLSchema#string

Uma Ladiwala

http://www.w3.org/2001/XMLSchema#string

P2860

The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus

The molecular neurobiology of depression

Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors

The pharmacology of putative early-onset antidepressant strategies

Expression of brain derived neurotrophic factor, activity-regulated cytoskeleton protein mRNA, and enhancement of adult hippocampal neurogenesis in rats after sub-chronic and chronic treatment with the triple monoamine re-uptake inhibitor tesofensine

Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA

Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals

Transiently overexpressed alpha2-adrenoceptors and their control of DNA synthesis in the developing brain

VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

Noradrenaline is essential for mouse fetal development

P304

1096-1109

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.2309-09.2010

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Vidita A Vaidya

Swananda Marathe

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20089918

http://www.w3.org/2001/XMLSchema#string

P932

2880491

http://www.w3.org/2001/XMLSchema#string